Minnie Kuo
First SEC filing: Dec. 22, 2025 · Latest: Dec. 22, 2025
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 17, 2026 | PLRX | D | 150,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 17, 2026 | PLRX | A | 150,000 | · | · | 150,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 17, 2026 | PLRX | D | 40,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 17, 2026 | PLRX | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 17, 2026 | PLRX | D | 55,200 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 17, 2026 | PLRX | A | 55,200 | · | · | 55,200 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 22, 2026 | PLRX | A | 300,000 | · | · | 300,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 20, 2026 | PLRX | S 10b5-1 | 6,917 | $1.28 | $8,854 | 37,806 Direct | -15.47% | Disposed | -19.1% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 17, 2026 | PLRX | Stock Option (Right to Buy) | Common Stock | $16.18 | Sept. 14, 2033 | 150,000 | Disposed |
| April 17, 2026 | PLRX | Stock Option (Right to Buy) | Common Stock | · | Sept. 14, 2033 | 150,000 | Acquired |
| April 17, 2026 | PLRX | Stock Option (Right to Buy) | Common Stock | $17.44 | Jan. 23, 2034 | 40,000 | Disposed |
| April 17, 2026 | PLRX | Stock Option (Right to Buy) | Common Stock | · | Jan. 23, 2034 | 40,000 | Acquired |
| April 17, 2026 | PLRX | Stock Option (Right to Buy) | Common Stock | $11.14 | Jan. 23, 2035 | 55,200 | Disposed |
| April 17, 2026 | PLRX | Stock Option (Right to Buy) | Common Stock | · | Jan. 23, 2035 | 55,200 | Acquired |
| Jan. 22, 2026 | PLRX | Stock Option (Right to Buy) | Common Stock | $1.30 | Jan. 22, 2036 | 300,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $470,696 | $188,279 | · | · | $103,553 | · | $11,942 | $1,542,854 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.